SCHEMBL1298498

SCHEMBL1298498

CC(C)CCCCCOC1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.41
LMNA P02545 1/20 0.33
NAAA Q02083 2/20 0.33
LNPEP Q9UIQ6 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24779960 0.92 NPC1 (0.44) NPC1LMNANAAALNPEP
SCHEMBL24508705 0.86 NPC1 (0.36) NPC1LMNA
SCHEMBL9128054 0.84 NPC1 (0.47) NPC1LNPEP
SCHEMBL9251921 0.84 NPC1 (0.47) NPC1LNPEP
SCHEMBL9011791 0.83 NPC1 (0.54) NPC1NAAA
SCHEMBL262805 0.83 NPC1 (0.54) NPC1NAAA
SCHEMBL9011906 0.83 NPC1 (0.54) NPC1NAAA
SCHEMBL9011682 0.83 NPC1 (0.54) NPC1NAAA
SCHEMBL9251176 0.81 NPC1 (0.43) NPC1LNPEP
SCHEMBL2513761 0.81 NPC1 (0.50) NPC1NAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 285 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12599693-B2 Augmented thermoset polymer sponges for in situ hemostatic treatment of external and internal wounds UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2026-04-14 US claimed
US-12582132-B2 Germination/sprouting and fruit ripening regulators THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 2026-03-24 US claimed
US-20260078544-A1 SIZING AGENTCOMPRISING FUNCTIONALIZED POLYOLEFINS SABIC GLOBAL TECHNOLOGIES BV (NL) 2026-03-19 US claimed
EP-4692785-A1 PREPARATION LIQUID FOR ANALYZING HEMOGLOBIN COMPONENT, AND METHOD FOR MEASURING HEMOGLOBIN COMPONENT Tosoh Corporation (JP) 2026-02-11 EP claimed
US-20250134801-A1 NOVEL METHODS FOR DECELLULARIZING EXTRACELLULAR MATRIX REGENX SCIENCE, INC. (US) 2025-05-01 US claimed
US-20250098692-A1 GERMINATION/SPROUTING AND FRUIT RIPENING REGULATORS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE 2025-03-27 US claimed
EP-4475859-A2 NOVEL METHODS FOR DECELLULARIZING EXTRACELLULAR MATRIX Regenx Science, Inc. (US) 2024-12-18 EP claimed
CN-118973593-A Novel method for decellularizing extracellular matrix 瑞根克斯科学股份有限公司 2024-11-15 CN claimed
WO-2024203230-A1 PREPARATION LIQUID FOR ANALYZING HEMOGLOBIN COMPONENT, AND METHOD FOR MEASURING HEMOGLOBIN COMPONENT 東ソー株式会社 2024-10-03 WO claimed
US-12087950-B2 Gas diffusion layer for metal-air battery, method of manufacturing the same, and metal-air battery including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-09-10 US claimed
EP-4363571-A1 AUTOMATED PLASMID EXTRACTION Xpress Biologics (BE) 2024-05-08 EP claimed
US-20240132537-A1 METHOD FOR PURIFYING A PROTEIN OF INTEREST XPRESS BIOLOGICS (BE) 2024-04-25 US claimed
EP-4298106-A1 METHOD FOR PURIFYING A PROTEIN OF INTEREST Xpress Biologics (BE) 2024-01-03 EP claimed
EP-4232596-A1 KIT AND METHOD Primer Design Ltd (GB) 2023-08-30 EP claimed
WO-2023154873-A2 NOVEL METHODS FOR DECELLULARIZING EXTRACELLULAR MATRIX REGENX SCIENCE, INC. (US) 2023-08-17 WO claimed
WO-2023275406-A1 AUTOMATED PLASMID EXTRACTION XPRESS BIOLOGICS (BE) 2023-01-05 WO claimed
WO-2022180264-A1 METHOD FOR PURIFYING A PROTEIN OF INTEREST XPRESS BIOLOGICS (BE) 2022-09-01 WO claimed
WO-2022084381-A1 KIT AND METHOD Primer Design Limited (GB) 2022-04-28 WO claimed
EP-2456833-B1 SOLVENT-BASED INKJET INK FORMULATIONS MARKEM-IMAJE CORP (US) 2017-04-12 EP claimed
EP-2456833-A1 SOLVENT-BASED INKJET INK FORMULATIONS Markem-Imaje Corporation (US) 2012-05-30 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12599693-B2 Augmented thermoset polymer sponges for in situ hemostatic treatment of external and internal wounds HBG2, F8, HBG1 NPC1 4878/4885LMNA 2839/4885NAAA 3157/4885
US-12582132-B2 Germination/sprouting and fruit ripening regulators TAS2R31, MYB, TAS1R3 NPC1 3602/4885LMNA 4353/4885NAAA 147/4885
US-20250098692-A1 GERMINATION/SPROUTING AND FRUIT RIPENING REGULATORS BOLA2; BOLA2B, BROX, CDK5 NPC1 4755/4885LMNA 4528/4885NAAA 251/4885
US-20260078544-A1 SIZING AGENTCOMPRISING FUNCTIONALIZED POLYOLEFINS PUF60, SLFN12, SMCHD1 NPC1 2214/4885LMNA 1132/4885NAAA 2889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.